GlassScriptPhysician profile
Ronald A Shore
NPI 1649272915
$257.14
in general payments reported to CMS, 2019-2025
8 companies · $72.46 in 2025
The $72.46 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.00 · 2022: $28.52 · 2023: $30.23 · 2024: $111 · 2025: $72.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.43 | 2019-2024 | Xifaxan |
| Glaukos Corporation | $45.69 | 2024 | Idose |
| Madrigal Pharmaceuticals | $37.36 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $33.00 | 2024-2025 | Tremfya |
| Phathom Pharmaceuticals, INC. | $32.06 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $18.37 | 2024 | Omvoh |
| Qol Medical, LLC | $16.48 | 2023 | Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $13.75 | 2023 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Shore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.